Detalles de la búsqueda
1.
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.
Circulation
; 101(3): 239-43, 2000 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-10645918
2.
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.
Circulation
; 101(23): 2690-5, 2000 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-10851205
3.
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.
Clin Chim Acta
; 298(1-2): 85-97, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10876006
4.
Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.
Evid Rep Technol Assess (Summ)
; (78): 2p., 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12751155
5.
A practical approach to the diagnosis and management of thrombocytopenia associated with glycoprotein IIb/IIIa receptor inhibitors.
J Thromb Thrombolysis
; 9(2): 175-80, 2000 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-10613999
Resultados
1 -
5
de 5
1
Próxima >
>>